Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence
Xinmei Xu, Huan Yi, Jiasi Wu, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110984-110984
Open Access | Times Cited: 156

Showing 1-25 of 156 citing articles:

Probiotics, Prebiotics, and Phytogenic Substances for Optimizing Gut Health in Poultry
Awad A. Shehata, Sakine Yalçın, Juan D. Latorre, et al.
Microorganisms (2022) Vol. 10, Iss. 2, pp. 395-395
Open Access | Times Cited: 144
Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine
Sneha Singh, Nandini Pathak, Eram Fatima, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113839-113839
Closed Access | Times Cited: 130
Leaky Gut and the Ingredients That Help Treat It: A Review
Ricardo S. Alemán, Marvin Moncada, Kayanush J. Aryana
Molecules (2023) Vol. 28, Iss. 2, pp. 619-619
Open Access | Times Cited: 91
Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials
Ajaikumar B. Kunnumakkara, Mangala Hegde, Parama Dey, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 4, pp. 447-518
Open Access | Times Cited: 80
The mechanism of microglia-mediated immune inflammation in ischemic stroke and the role of natural botanical components in regulating microglia: A review
Jinsong Zeng, Tingting Bao, Kailin Yang, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 70
Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus
Leilei Du, Qi Li, Huan Yi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112839-112839
Open Access | Times Cited: 67
The Janus face of mitophagy in myocardial ischemia/reperfusion injury and recovery
Jiaxin Deng, Qian Liu, L Ye, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116337-116337
Open Access | Times Cited: 27
Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases
Zeinab Nouri, Ashkan Barfar, Sahra Perseh, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Drug Advances in NAFLD: Individual and Combination Treatment Strategies of Natural Products and Small-Synthetic-Molecule Drugs
Xing Wan, Jingyuan Ma, He Bai, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 140-140
Open Access | Times Cited: 1
Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR’s cholesterol-decreasing efficacy in patients
Chongming Wu, Ying Zhao, Yingying Zhang, et al.
Journal of Advanced Research (2021) Vol. 37, pp. 197-208
Open Access | Times Cited: 58
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy
Yaoyuan Zhang, Zhu Xiao, Xinyuan Yu, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 36
Dietary flavonoids and gut microbiota interaction: A focus on animal and human studies to maximize their health benefits
Yang Li, Yongchao Gao, Mohamed A. Farag, et al.
Food Frontiers (2023) Vol. 4, Iss. 4, pp. 1794-1809
Open Access | Times Cited: 32
A Review of Fibraurea tinctoria and Its Component, Berberine, as an Antidiabetic and Antioxidant
Indah Purwaningsih, Iman Permana Maksum, Dadan Sumiarsa, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1294-1294
Open Access | Times Cited: 30
Dioscorea spp.: Bioactive Compounds and Potential for the Treatment of Inflammatory and Metabolic Diseases
Zhen Wang, Sheng-Nan Zhao, Siyu Tao, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2878-2878
Open Access | Times Cited: 29
From Xiaoke to diabetes mellitus: a review of the research progress in traditional Chinese medicine for diabetes mellitus treatment
Xianglong Meng, Xiaoqin Liu, Jiaying Tan, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 26
Management and control of coccidiosis in poultry — A review
Rafiq Ahmad, Yu‐Hsiang Yu, Kuo‐Feng Hua, et al.
Animal Bioscience (2023) Vol. 37, Iss. 1, pp. 1-15
Open Access | Times Cited: 21
Kaempferol efficacy in metabolic diseases: Molecular mechanisms of action in diabetes mellitus, obesity, non-alcoholic fatty liver disease, steatohepatitis, and atherosclerosis
Yuxin Yao, Yujie Yu, Shu Dai, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116694-116694
Open Access | Times Cited: 12
Berberine, a natural alkaloid: Advances in its pharmacological effects and mechanisms in the treatment of autoimmune diseases
Zhifang Qin, Ran Tang, Juan Liang, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112422-112422
Closed Access | Times Cited: 11
A mini review on human serum albumin - natural alkaloids interaction and its role as drug carrier
Tapas Ghosh, Kakali Bhadra
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-18
Closed Access | Times Cited: 10
Advanced sample preparation and chromatographic techniques for analyzing plant-based bioactive chemicals in nutraceuticals
Muhammed Mesud HÜRKUL, Ahmet Çetinkaya, Şeyda YAYLA, et al.
Journal of Chromatography Open (2024) Vol. 5, pp. 100131-100131
Open Access | Times Cited: 8
Plant antibacterials: The challenges and opportunities
Tomayo Berida, Yemi A. Adekunle, Hannah Dada-Adegbola, et al.
Heliyon (2024) Vol. 10, Iss. 10, pp. e31145-e31145
Open Access | Times Cited: 7
Berberis kansuensis extract alleviates type 2 diabetes in rats by regulating gut microbiota composition
Tong Xu, Yiman Ge, Huan Du, et al.
Journal of Ethnopharmacology (2021) Vol. 273, pp. 113995-113995
Closed Access | Times Cited: 49
The natural product berberine synergizes with osimertinib preferentially against MET-amplified osimertinib-resistant lung cancer via direct MET inhibition
Zhen Chen, Karin A. Vallega, Haiying Chen, et al.
Pharmacological Research (2021) Vol. 175, pp. 105998-105998
Open Access | Times Cited: 44
Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
Sa Yang, Shijie Cao, Congyu Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
Dietary berberine alleviates high carbohydrate diet-induced intestinal damages and improves lipid metabolism in largemouth bass (Micropterus salmoides)
Yulong Gong, Qisheng Lu, Yulong Liu, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top